Literature DB >> 4021521

Surgical treatment of chronic empyema. A new one-stage operation.

S Iioka, K Sawamura, T Mori, K Iuchi, K Nakamura, Y Monden, Y Kawashima.   

Abstract

The operative results in a series of 92 patients with chronic empyema were reviewed. Of these, 46 had empyema with an underlying fistula, and 46 had empyema without fistulization. Twenty-one underwent decortication, 65 were treated by our technique, and six were treated by a modification of the Eloesser technique. These techniques were employed with priority given in the order just cited. Our technique involves decortication of the visceral peel and obliteration of the dead space by collapsing of the parietal wall without rib resection. Cure was obtained with decortication alone in 20 of 21 patients. Sixty of 65 patients treated by our technique were cured without deformation of the thoracic cage. In all patients treated by the modified Eloesser technique, obliteration of the empyema cavity was achieved secondarily by thoracoplasty combined with a pedicled muscle flap. Postoperative pulmonary function studies demonstrated a significant improvement in vital capacity and forced expiratory volume in 1 second in patients treated by decortication or by our technique. With the modified Eloesser technique, in contract, pulmonary function tended to decline.

Entities:  

Mesh:

Year:  1985        PMID: 4021521

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

Review 1.  Surgical treatment of chronic empyema.

Authors:  Yuji Shiraishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-07-14

2.  Treatment of tuberculous empyema with multiple fistulae by reexpansion of the affected lung and restoration of its function: report of a case.

Authors:  N Tsubota; A Murotani; M Yoshimura; Y Miyamoto; Y Maniwa
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

3.  Postoperative pyothorax.

Authors:  H Ueda; K Shibata; T Kusano
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.